Mifamurtide

CAS : 83461-56-7

Ref. TM-T12037

Informations sur le produit

• Nom: Mifamurtide
• Synonymes: MTP-PE, L-MTP-PE, CGP 19835, 13-Carbamoyl-4-Formyl-27-(Hexadecanoyloxy)-24-Hydroxy-7,10,18-Trimethyl-24-Oxido-2,8,11,16,19-Pentaoxo-5-(1,2,3-Trihydroxypropyl)-6,23,25-Trioxa-3,9,12,17,20-Pentaaza-24Lambda~5~-Phosphaoctacosan-28-Yl Hexadecanoate (Non-Preferred Name), <span class="text-smallcaps">L</smallcap>-Alaninamide, N-(N-acetylmuramoyl)-<smallcap>L</smallcap>-alanyl-<smallcap>D</span>-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, <span class="text-smallcaps">L</smallcap>-Alaninamide, N-(N-acetylmuramoyl)-<smallcap>L</smallcap>-alanyl-<smallcap>D</span>-α-glutaminyl-N-[4-hydroxy-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, P-oxide, (R)-, Cgp 19835, Cgp-19835A, L-Mtp-Pe, Mepact, Mlv 19835, Mlv-19835A, Mtp-Pe, Muramoyl tripeptide phosphatidylethanolamine, N-(N-Acetylmuramoyl)-<span class="text-smallcaps">L</smallcap>-alanyl-<smallcap>D</smallcap>-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-<smallcap>L</span>-alaninamide, N-Acetylmuramyl-L-alanyl-D-isoglutamine-L-alanine 2-(1',2'-dipalmitoyl-sn-glycero-3'-hydroxyphosphoryloxy)ethylamide, N-(N-Acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide, L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[4-hydroxy-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, P-oxide, (R)-

Description

Mifamurtide is a drug against osteosarcoma, is an immunomodulator with antitumor effects.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 1237.5
• Formule: C₅₉H₁₀₉N₆O₁₉P
• Degré de pureté: 98%
• Couleur/Forme: Solid